Welcome to Markets Desk, here's what's moving the needle this Friday.
Eli Lilly remains one of the most closely watched names in large-cap pharma, and for good reason. The company has executed sharply on its position in the GLP-one space, turning a first-mover advantage into sustained commercial momentum. The three factors shaping its outlook now center on pipeline depth, pricing durability, and competitive pressure from Novo Nordisk.
Shifting to the grain pits, wheat is the standout commodity story heading into the weekend. Chicago soft red winter contracts surged as much as twenty-four and a quarter cents on Friday, pushing winter wheat benchmarks to three-year highs. Kansas City hard red winter futures matched that move, signaling broad-based fundamental support rather than a single-contract technical squeeze.
And stepping back to the macro picture, the debate over the shape of today's economy is getting sharper. Economists who long agreed the post-pandemic recovery was K-shaped, meaning divergent outcomes between higher and lower earners, are now splitting. Some see a C, others an E, reflecting a more fragmented and regionally uneven growth picture than any single letter can capture.
That's the tape. Markets Desk, signing off the floor.
